The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes.

PubWeight™: 2.62‹?› | Rank: Top 1%

🔗 View Article (PMID 14754776)

Published in Am J Psychiatry on February 01, 2004

Authors

François Lespérance1, Nancy Frasure-Smith, Pierre Théroux, Michael Irwin

Author Affiliations

1: Department of Psychiatry, Centre Hospitalier de l'Université de Montréal, Quebec, Canada. francois.lesperance@umontreal.ca

Articles citing this

Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49

Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med (2006) 2.55

Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44

Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28

Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med (2010) 2.06

Psychiatry as a clinical neuroscience discipline. JAMA (2005) 2.00

Maternal warmth buffers the effects of low early-life socioeconomic status on pro-inflammatory signaling in adulthood. Mol Psychiatry (2010) 1.90

Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry (2008) 1.70

The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res (2011) 1.63

Cytokine, sickness behavior, and depression. Neurol Clin (2006) 1.58

Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am (2009) 1.56

The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial. Int J Nurs Stud (2010) 1.52

Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med (2010) 1.39

Socioeconomic and psychosocial predictors of interleukin-6 in the MIDUS national sample. Health Psychol (2010) 1.39

Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry (2008) 1.27

AAFP guideline for the detection and management of post-myocardial infarction depression. Ann Fam Med (2009) 1.20

Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol (2008) 1.19

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am (2009) 1.08

Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy. Paediatr Perinat Epidemiol (2011) 1.06

Risk of placental abruption in relation to maternal depressive, anxiety and stress symptoms. J Affect Disord (2010) 1.03

Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun (2008) 1.03

Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med (2008) 1.01

Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart (2006) 0.95

Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun (2009) 0.94

Major depression and coronary flow reserve detected by positron emission tomography. Arch Intern Med (2009) 0.93

Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet (2009) 0.91

Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity (Silver Spring) (2013) 0.87

Inflammation a possible link between economical stress and coronary heart disease. Eur J Epidemiol (2007) 0.87

Risk of spontaneous preterm birth in relation to maternal exposure to intimate partner violence during pregnancy in Peru. Matern Child Health J (2013) 0.87

Moderating effects of moderate-intensity physical activity in the relationship between depressive symptoms and interleukin-6 in primary care patients. Psychosom Med (2011) 0.85

Psychosocial stress and cardiovascular diseases. Postgrad Med J (2005) 0.83

Depression and coronary heart disease. ISRN Cardiol (2012) 0.82

Association between intimate partner violence, migraine and probable migraine. Headache (2010) 0.82

Psychological factors in asthma. Allergy Asthma Clin Immunol (2008) 0.82

Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study. Horm Metab Res (2009) 0.82

Is chronic inflammation a possible cause of obesity-related depression? Mediators Inflamm (2009) 0.81

Hemodynamic changes in depressive patients. J Zhejiang Univ Sci B (2006) 0.80

Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study. BMC Psychiatry (2016) 0.80

Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes. J Affect Disord (2011) 0.79

Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression. Int J Geriatr Psychiatry (2012) 0.78

Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events. Biol Res Nurs (2009) 0.78

High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome. BMC Cardiovasc Disord (2015) 0.78

Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? J Psychiatry Neurosci (2004) 0.77

The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design. BMC Neurol (2016) 0.76

Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma. Rev Bras Psiquiatr (2010) 0.76

Maternal Uncontrolled Anxiety Disorders Are Associated With the Increased Risk of Hypertensive Disorders in Japanese Pregnant Women. J Clin Med Res (2015) 0.75

Inflammatory markers, depression, and cardiac disease. Am J Psychiatry (2005) 0.75

Impact of daily lifestyle on coronary heart disease. Exp Ther Med (2015) 0.75

Depression, daily stressors and inflammatory responses to high-fat meals: when stress overrides healthier food choices. Mol Psychiatry (2016) 0.75

Articles by these authors

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA (2007) 6.06

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation (2008) 5.15

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04

Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81

Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65

Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55

Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation (2002) 3.47

Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. J Am Coll Cardiol (2012) 2.77

Job strain and risk of acute recurrent coronary heart disease events. JAMA (2007) 2.61

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50

Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation (2011) 2.36

Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med (2006) 2.13

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96

Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation (2009) 1.79

Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol (2004) 1.76

Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol (2005) 1.53

A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction. Am Heart J (2003) 1.40

Immune activation and depression in women with rheumatoid arthritis. J Rheumatol (2004) 1.34

Depression and anxiety and outcomes of coronary artery bypass surgery. Ann Thorac Surg (2003) 1.31

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol (2011) 1.25

Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry (2007) 1.21

The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry (2010) 1.21

Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment. Evid Based Complement Alternat Med (2004) 1.18

Depression--a cardiac risk factor in search of a treatment. JAMA (2003) 1.14

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years. Int J Cardiol (2012) 1.12

Depression and cardiac risk: present status and future directions. Heart (2009) 1.11

Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom Med (2003) 1.08

Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom Med (2003) 1.02

AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Endorsed by the American Psychiatric Association. Prog Cardiovasc Nurs (2009) 0.97

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials. Circ Cardiovasc Qual Outcomes (2011) 0.95

Chronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelines. Pain Physician (2014) 0.94

Cellular adhesion molecule expression, nocturnal sleep, and partial night sleep deprivation. Brain Behav Immun (2004) 0.94

Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation (2009) 0.92

An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Can J Psychiatry (2003) 0.91

The efficacy of a motivational nursing intervention based on the stages of change on self-care in heart failure patients. J Cardiovasc Nurs (2010) 0.91

Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet (2009) 0.91

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. Am Heart J (2002) 0.90

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. Ann Behav Med (2006) 0.90

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol (2011) 0.88

Depression and heart disease. Cleve Clin J Med (2007) 0.88

Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. Contemp Clin Trials (2012) 0.86

Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study. J Am Coll Cardiol (2008) 0.86

Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes. Eur Heart J (2011) 0.85

Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes. Am Heart J (2005) 0.85

Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use. Can J Cardiol (2002) 0.85

Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. PLoS One (2011) 0.84

Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J (2005) 0.84

An open-label trial of interpersonal psychotherapy in depressed patients with coronary disease. Psychosomatics (2004) 0.84

Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre. Can J Cardiol (2006) 0.83

Inequities in medical follow-up for depression: a population-based study in Montreal. Psychiatr Serv (2010) 0.83

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. Eur Heart J Acute Cardiovasc Care (2013) 0.83

Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolysis (2008) 0.82

Depression and cardiac risk: present status and future directions. Postgrad Med J (2010) 0.82

Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics. Can J Cardiol (2011) 0.82

Depression as a risk factor for post-MI mortality. J Am Coll Cardiol (2004) 0.81

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. J Thorac Cardiovasc Surg (2003) 0.81

Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline? Can J Physiol Pharmacol (2007) 0.81

Randomized controlled trial of tailored nursing interventions to improve cardiac rehabilitation enrollment. Nurs Res (2012) 0.81

Nursing approaches to reducing psychological distress in men and women recovering from myocardial infarction. Int J Nurs Stud (2002) 0.81

Myocardial perfusion study of panic attacks in patients with coronary artery disease. Am J Cardiol (2005) 0.80

Bridging the transition from hospital to home: effects of the VITAL telehealth program on recovery for CABG surgery patients and their caregivers. Res Nurs Health (2013) 0.80

N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction. Can J Cardiol (2006) 0.80

The INTERHEART study: intersection between behavioral and general medicine. Psychosom Med (2004) 0.79

Sertraline for treatment of depression in acute coronary syndromes. JAMA (2002) 0.79

Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder? Am Heart J (2004) 0.79

Spontaneous cardiomyopathy in cynomolgus monkeys (Macaca fascicularis). Toxicol Pathol (2009) 0.78

Effect of inhibition of the Na+/H+ exchanger with cariporide on left ventricular function in acute coronary syndromes: results from the echocardiographic substudy of the GUARDIAN trial. Can J Cardiol (2004) 0.78

A pilot randomized trial of a smoking cessation nursing intervention in cardiac patients after hospital discharge. Can J Cardiovasc Nurs (2012) 0.78

Depression and coronary artery disease: time to move from observation to trials. CMAJ (2003) 0.77

Additive effects of obesity and TCF7L2 variants on risk for type 2 diabetes among cardiac patients. Diabetes Care (2007) 0.77

[A pre assessment for nursing intervention to support tobacco cessation in patients hospitalized for cardiac problems: a pilot study (So-Live)]. Rech Soins Infirm (2011) 0.77

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J (2006) 0.77

Coronary heart disease and depression: the next steps. Can J Psychiatry (2006) 0.77

Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination. Clin Biochem (2004) 0.77

A trend toward improved learning of cardiovascular pathophysiology in medical students from using a human patient simulator: results of a pilot study. Adv Physiol Educ (2007) 0.77

First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial. J Psychosom Res (2010) 0.77

The systematic development of a nursing intervention aimed at increasing enrollment in cardiac rehabilitation for acute coronary syndrome patients. Prog Cardiovasc Nurs (2009) 0.76

Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study. Neuropsychopharmacology (2007) 0.76

Pharmacotherapy for acute pain in children: current practice and recent advances. Expert Opin Pharmacother (2011) 0.75

Depressive Symptoms and 24-Hour Ambulatory Blood Pressure in Africans: The SABPA Study. Int J Hypertens (2011) 0.75

Home or hospital: choices at the end of life. J R Soc Med (2004) 0.75

Post-traumatic disorder symptoms and blunted diurnal cortisol production in partners of prostate cancer patients. Psychoneuroendocrinology (2012) 0.75

Am I breaking the law again? BMJ (2004) 0.75

Probable need for psychiatric treatment is not the same as depression. Eur Heart J (2004) 0.75

Pro-choice living wills. Bull Med Ethics (2004) 0.75

Classification and risk stratification of patients with acute chest pain using a low discriminatory level of cardiac troponin T. Clin Cardiol (2004) 0.75

In support of assisted dying. BMJ (2015) 0.75

Visual EEG differences in abstinent alcohol dependence and ethnicity. Sleep Med (2005) 0.75

Macrophage colony-stimulating factor expression in retrovirally transduced cells is dependent upon both the adherence status of the target cells and its 5' flanking untranslated region. Biochem Biophys Res Commun (2005) 0.75